These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17875703)

  • 1. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.
    Whiteman HJ; Weeks ME; Dowen SE; Barry S; Timms JF; Lemoine NR; Crnogorac-Jurcevic T
    Cancer Res; 2007 Sep; 67(18):8633-42. PubMed ID: 17875703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100P promotes pancreatic cancer growth, survival, and invasion.
    Arumugam T; Simeone DM; Van Golen K; Logsdon CD
    Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.
    Vimalachandran D; Greenhalf W; Thompson C; Lüttges J; Prime W; Campbell F; Dodson A; Watson R; Crnogorac-Jurcevic T; Lemoine N; Neoptolemos J; Costello E
    Cancer Res; 2005 Apr; 65(8):3218-25. PubMed ID: 15833853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100P is an early developmental marker of pancreatic carcinogenesis.
    Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
    Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
    Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.
    Ohuchida K; Mizumoto K; Ishikawa N; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2005 Nov; 11(21):7785-93. PubMed ID: 16278400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.
    Crnogorac-Jurcevic T; Missiaglia E; Blaveri E; Gangeswaran R; Jones M; Terris B; Costello E; Neoptolemos JP; Lemoine NR
    J Pathol; 2003 Sep; 201(1):63-74. PubMed ID: 12950018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
    Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
    Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK
    Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
    Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
    Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of calcium-related genes in gastric cancer cells transfected with cellular prion protein.
    Liang J; Luo G; Ning X; Shi Y; Zhai H; Sun S; Jin H; Liu Z; Zhang F; Lu Y; Zhao Y; Chen X; Zhang H; Guo X; Wu K; Fan D
    Biochem Cell Biol; 2007 Jun; 85(3):375-83. PubMed ID: 17612632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.
    Kato S; Kubota K; Shimamura T; Shinohara Y; Kobayashi N; Watanabe S; Yoneda M; Inamori M; Nakamura F; Ishiguro H; Nakaigawa N; Nagashima Y; Taguri M; Kubota Y; Goshima Y; Morita S; Endo I; Maeda S; Nakajima A; Nakagama H
    Cancer Sci; 2011 Nov; 102(11):2029-37. PubMed ID: 21812859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
    Ohuchida K; Mizumoto K; Lin C; Yamaguchi H; Ohtsuka T; Sato N; Toma H; Nakamura M; Nagai E; Hashizume M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19(7):2394-402. PubMed ID: 22407312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100P expression in human esophageal epithelial cells: Human esophageal epithelial cells sequentially produce different S100 proteins in the process of differentiation.
    Sato N; Hitomi J
    Anat Rec; 2002 May; 267(1):60-9. PubMed ID: 11984793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells.
    Neesse A; Gangeswaran R; Luettges J; Feakins R; Weeks ME; Lemoine NR; Crnogorac-Jurcevic T
    Oncogene; 2007 Mar; 26(11):1533-45. PubMed ID: 16983343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer.
    Dowen SE; Crnogorac-Jurcevic T; Gangeswaran R; Hansen M; Eloranta JJ; Bhakta V; Brentnall TA; Lüttges J; Klöppel G; Lemoine NR
    Am J Pathol; 2005 Jan; 166(1):81-92. PubMed ID: 15632002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
    Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
    Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.
    He Z; Gao J; Wang Q; Liu M; Li Y; Li X; Tang H; Zheng J
    Oncol Rep; 2008 Aug; 20(2):325-32. PubMed ID: 18636193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-phase reduction in T47D human breast cancer epithelial cells induced by an S100P antisense-retroviral construct.
    Beissel B; Silva ID; Pesquero JB; Russo J; Schor N; Bellini MH
    Oncol Rep; 2007 Mar; 17(3):611-5. PubMed ID: 17273741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.